Intuitive Surgical (ISRG)
526.05
-2.08 (-0.39%)
NASDAQ · Last Trade: Jul 11th, 3:53 AM EDT
Detailed Quote
Previous Close | 528.13 |
---|---|
Open | 527.10 |
Bid | 522.00 |
Ask | 526.58 |
Day's Range | 520.25 - 528.55 |
52 Week Range | 413.82 - 616.00 |
Volume | 1,424,682 |
Market Cap | 188.54B |
PE Ratio (TTM) | 77.02 |
EPS (TTM) | 6.8 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,633,816 |
Chart
About Intuitive Surgical (ISRG)
Intuitive Surgical is a pioneering medical device company specializing in robotic-assisted surgical systems, most notably the da Vinci Surgical System. This innovative platform enhances the precision and control of minimally invasive surgical procedures, enabling surgeons to perform operations with greater accuracy and reduced recovery times for patients. The company is dedicated to advancing the field of robotics in surgery, providing training and support for healthcare professionals, and continually innovating its technology to improve patient outcomes across various medical specialties. Read More
News & Press Releases
Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical instrument designed to seal, cut, grasp, and dissect tissue for use with Intuitive’s da Vinci surgical systems.
Via Stocktwits · July 10, 2025
Intuitive’s latest advanced energy instrument features a unique curved tip for enhanced precision
By Intuitive Surgical, Inc. · Via GlobeNewswire · July 10, 2025
INTUITIVE SURGICAL (NASDAQ:ISRG) is a strong growth stock with solid fundamentals and a promising technical setup, making it a candidate for further upside.
Via Chartmill · July 10, 2025
The parabolic ascent of artificial intelligence (AI) superstar Palantir Technologies may be short-lived.
Via The Motley Fool · July 4, 2025
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
Via StockStory · July 4, 2025
Via Benzinga · July 3, 2025
Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures
By Intuitive Surgical, Inc. · Via GlobeNewswire · July 2, 2025
Via Benzinga · June 27, 2025
Cathie Wood's ARK Invest predicts $250 billion potential GDP boost from widespread adoption of humanoid robots.
Via Benzinga · June 24, 2025
Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?
Via MarketBeat · June 19, 2025
Wedbush Fund Advisers CIO Cullen Rogers tells Benzinga: "We don't react to short-term performance or headlines."
Via Benzinga · June 17, 2025
Over the past six months, Intuitive Surgical’s stock price fell to $516.25. Shareholders have lost 5.3% of their capital, disappointing when considering the S&P 500 was flat. This may have investors wondering how to approach the situation.
Via StockStory · June 17, 2025
Via Benzinga · June 13, 2025
Intuitive Surgical remains in focus as analysts weigh reprocessing risks after Restore Robotics secures FDA clearance for remanufactured tools.
Via Benzinga · June 13, 2025
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution.
While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Via StockStory · June 12, 2025
Intuitive Surgical stock: Though the recent correction may raise concerns, Adhishthana Principles suggest the pullback is both expected and healthy.
Via Benzinga · June 11, 2025

Via The Motley Fool · June 10, 2025
One former Intuitive Surgical fan thinks it's time to sell the stock.
Via The Motley Fool · June 9, 2025
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Monday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · June 9, 2025
Shares of medical technology company Intuitive Surgical (NASDAQ:ISRG) fell 6.2% in the afternoon session after Deutsche Bank cut the stock's rating from Hold to Sell and slashed its price target to $440 from $515, after identifying accelerating competition from lower-cost remanufactured instruments in the Instruments & Accessories segment.
Via StockStory · June 9, 2025